Strategic Developments Reshaping the Monoclonal Antibody Therapy Market
The demand for monoclonal antibody therapies is experiencing unprecedented growth, driven by the increasing prevalence of chronic diseases and advancements in biotechnology. According to , the monoclonal antibody therapy market is set to reach USD 232.1 billion by 2035, indicating a consistent increase in both market size and demand. As healthcare systems evolve, the therapeutic applications of...
0 Commentarios 0 Acciones 3 Views 0 Vista previa